glp-1 obesity drug news today october 2025 WHO Decision Recognizing as a Disease Treatable with Drugs Is “Big Deal,” says BU Endocrinologist | BU GLP-1 Agonists Weight Loss Drugs

Staying at each dose level for 6 weeks instead of 4 reduces side effects for sensitive individuals

Your path to significant weight loss with cagrilintide requires commitment to proper titration, managing side effects proactively, maintaining adequate protein and hydration, supporting with diet and exercise, and understanding this is a long-term approach requiring 12-18+ months for maximum results and ongoing maintenance to prevent regain

The 2024 average AOM semaglutide prescription rate amongst adolescents with obesity was 23.7-fold higher than the 2024 average AOM liraglutide prescription rate

It can worsen GI side effects, particularly nausea and bloating

Our wellness pen combination refill kit contains our two premium at-home refill kits, with one months supply of NAD+ and L-Glutathione

Biomedicines 10 , 3067 (2022)